TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Total Non-Current Liabilities (2020 - 2026)

Updated

TScan Therapeutics (TCRX) posted Total Non-Current Liabilities of $40.19 million for Q2 2026, down 67.0% from $121.73 million a year earlier but up 14.0% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, TScan Therapeutics' Total Non-Current Liabilities came in at $32.65 million, down 74.9% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
  • In prior years, TScan Therapeutics' Total Non-Current Liabilities was $130.01 million in FY2024, $99.61 million in FY2022 (+265.8%) and $27.23 million in FY2021 (-70.4%).
  • Quarterly Total Non-Current Liabilities has run from a low of $20.67 million in Q2 2022 to a high of $130.01 million in Q4 2024 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last four quarters, with an average decline of 43.3% over the last five quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2023, with growth of 511.1%; the weakest was Q2 2022, with a decline of 89.1%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $35.26 million (Q1 2026), $32.65 million (Q4 2025) and $117.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.26 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 60.81 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 102.65 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 117.60 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 79.95 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 36.05 Bn
9 Gsk 193.54 Bn 176.38 Bn - -43.16 Bn
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.19 Mn
Mar 31, 2026 35.26 Mn
Dec 31, 2025 32.65 Mn
Sep 30, 2025 117.93 Mn
Jun 30, 2025 121.73 Mn
Mar 31, 2025 122.38 Mn
Dec 31, 2024 130.01 Mn
Sep 30, 2024 118.79 Mn
Sep 30, 2023 122.41 Mn
Jun 30, 2023 126.29 Mn
Mar 31, 2023 95.52 Mn
Dec 31, 2022 99.61 Mn
Sep 30, 2022 48.70 Mn
Jun 30, 2022 20.67 Mn
Mar 31, 2022 22.41 Mn
Dec 31, 2021 27.23 Mn
Sep 30, 2021 30.58 Mn
Jun 30, 2021 189.80 Mn
Dec 31, 2020 91.96 Mn
API Access

TScan Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TCRX&period=max&api_key=YOUR_API_KEY